Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
QDEL Transcript
QuidelOrtho Corporation (QDEL) Q1 2026 Earnings Call Transcript
Unknown5-6
The earnings call reveals several concerning factors: negative cash flows, increased inventory levels, and a significant decline in respiratory revenue impacting overall margins. Additionally, the guidance for Q2 is flat, with uncertainties in China affecting revenue. Despite some positive developments in product launches and long-term margin improvements, the immediate outlook remains challenged. Given the company's small-cap status, these negative aspects are likely to result in a stock price decline over the next two weeks.
QuidelOrtho Corporation (QDEL) Q4 2025 Earnings Call Transcript
Unknown2-11
The earnings call provides mixed signals: while revenue and EBITDA guidance are positive, free cash flow fell short due to timing issues. The Q&A reveals sustainable growth in the Lab segment and strategic partnerships, but also highlights uncertainties in respiratory revenue and flat gross margins. The market cap indicates a moderate reaction, leading to a neutral prediction for stock price movement.
QuidelOrtho Corporation (QDEL) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Neutral12-3
Curaleaf Holdings, Inc. (CURA:CA) Q3 2025 Earnings Call Transcript
Unknown11-6
The earnings call presents mixed signals. Positive aspects include international growth, improved gross margins, and cash flow generation. However, declines in retail revenue, net loss, and unclear management responses on future margin expansion and regulatory impacts are concerns. The market cap suggests moderate volatility, leading to a neutral stock price prediction.
QDEL Slides
QDEL Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
